Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

First-in-Human Study of 89Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies

Christian Lohrmann, Eileen O'Reilly, Joseph ODonoghue, Kenneth H. Yu, Neeta Pandit-Taskar, Serge Lyashchenko, Shutian Ruan, Jiong Wu, Phillip DeNoble, Jorge Carrasquillo, Charles Schmidtlein, Rebecca Teng, Maeve A. Lowery, Anna Varghese, Hayley Estrella, Wolfgang Scholz, Paul Maffuid, Jason Lewis and Wolfgang Weber
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 385;
Christian Lohrmann
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eileen O'Reilly
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph ODonoghue
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth H. Yu
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neeta Pandit-Taskar
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Lyashchenko
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shutian Ruan
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiong Wu
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip DeNoble
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Carrasquillo
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Schmidtlein
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Teng
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maeve A. Lowery
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Varghese
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayley Estrella
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Scholz
1MabVax Therapeutics Holdings, Inc San Diego CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Maffuid
1MabVax Therapeutics Holdings, Inc San Diego CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Lewis
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Weber
2Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 385

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Christian Lohrmann2,
  2. Eileen O'Reilly2,
  3. Joseph ODonoghue2,
  4. Kenneth H. Yu2,
  5. Neeta Pandit-Taskar2,
  6. Serge Lyashchenko2,
  7. Shutian Ruan2,
  8. Jiong Wu2,
  9. Phillip DeNoble2,
  10. Jorge Carrasquillo2,
  11. Charles Schmidtlein2,
  12. Rebecca Teng2,
  13. Maeve A. Lowery2,
  14. Anna Varghese2,
  15. Hayley Estrella2,
  16. Wolfgang Scholz1,
  17. Paul Maffuid1,
  18. Jason Lewis2 and
  19. Wolfgang Weber2
  1. 1MabVax Therapeutics Holdings, Inc San Diego CA United States
  2. 2Memorial Sloan Kettering Cancer Center New York NY United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017400
Jun 201730700
Jul 20175200
Aug 20174600
Sep 20173500
Oct 20174300
Nov 20173300
Dec 20172100
Jan 20182100
Feb 20182000
Mar 20184000
Apr 20182300
May 20181600
Jun 20181000
Jul 20182200
Aug 20181600
Sep 20183300
Oct 20183200
Nov 20184100
Dec 20181000
Jan 20198600
Feb 20194100
Mar 20192600
Apr 20195500
May 20197300
Jun 20197300
Jul 201914200
Aug 20193000
Sep 20191500
Oct 20191700
Nov 20191700
Dec 2019500
Jan 2020600
Feb 20201300
Mar 20203500
Apr 20204000
May 2020700
Jun 20201800
Jul 20201200
Aug 20205100
Sep 20203400
Oct 20201900
Nov 20201600
Dec 20202200
Jan 20211200
Feb 20211900
Mar 20211800
Apr 20211800
May 20211600
Jun 20213100
Jul 20213000
Aug 20214100
Sep 20212900
Oct 20213000
Nov 20216500
Dec 20213500
Jan 20227100
Feb 20224100
Mar 20223400
Apr 20222900
May 20223300
Jun 20222200
Jul 20221100
Aug 20222700
Sep 20223500
Oct 20221000
Nov 20221200
Dec 20221000
Jan 20232300
Feb 20231400
Mar 20231800
Apr 20232300
May 20234900
Jun 20233100
Jul 20232200
Aug 20234500
Sep 20233600
Oct 20233400
Nov 20232000
Dec 20233200
Jan 20244400
Feb 20242500
Mar 20243800
Apr 20242600
May 20243000
Jun 20243500
Jul 20243000
Aug 20242000
Sep 20242400
Oct 20241400
Nov 20242100
Dec 20241100
Jan 20252400
Feb 20252600
Mar 20252000
Apr 20252400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-Human Study of 89Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-Human Study of 89Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
Christian Lohrmann, Eileen O'Reilly, Joseph ODonoghue, Kenneth H. Yu, Neeta Pandit-Taskar, Serge Lyashchenko, Shutian Ruan, Jiong Wu, Phillip DeNoble, Jorge Carrasquillo, Charles Schmidtlein, Rebecca Teng, Maeve A. Lowery, Anna Varghese, Hayley Estrella, Wolfgang Scholz, Paul Maffuid, Jason Lewis, Wolfgang Weber
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 385;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-Human Study of 89Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
Christian Lohrmann, Eileen O'Reilly, Joseph ODonoghue, Kenneth H. Yu, Neeta Pandit-Taskar, Serge Lyashchenko, Shutian Ruan, Jiong Wu, Phillip DeNoble, Jorge Carrasquillo, Charles Schmidtlein, Rebecca Teng, Maeve A. Lowery, Anna Varghese, Hayley Estrella, Wolfgang Scholz, Paul Maffuid, Jason Lewis, Wolfgang Weber
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 385;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

New Clinical Concepts and First-in-Human

  • The effect of 68Ga-PSMA-11 (HBED-CC) activity concentration reduction on image quality and detection of prostate cancer metastases
  • Clinical Translation of Gastrin Releasing Peptide Receptor Antagonist 68Ga-NOTA-RM26 in Healthy Volunteers and Prostate Cancer Patients
Show more New Clinical Concepts and First-in-Human

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire